Page 6 - Sven Francque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

INVENTIVA: Inventiva to host a webcast with Key Opinion Leaders following the EASL International Liver Congress 2022

Update on Inventiva's NATiV3 Phase III clinical trial evaluating lanifibranor in patients with NASH and fibrosis (stage F2/F3) non-cirrhotic by Prof. Sven FrancqueUpdate on the current NASH landscape by

New yorkUnited statesNoord hollandOnno holleboomInventiva pharmaSteven harrisonAude lepreuxStephen harrisonSven francqueMichael cooremanPascaline clercPierre broquaPatricial bankHepatology of the university hospital antwerpBrunswick groupExchange commission on

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva to host a webcast with Key Opinion Leaders following the EASL International Liver Congress™ 2022

Investegate announcements from INVENTIVA, Inventiva to host a webcast with Key Opinion Leaders following the EASL International Liver Congress™ 2022

New yorkUnited statesNoord hollandOnno holleboomInventiva pharmaSteven harrisonStephen harrisonAude lepreuxSven francqueMichael cooremanPascaline clercPierre broquaPatricial bankHepatology of the university hospital antwerpBrunswick groupExchange commission on

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces three scientific presentations at the EASL International Liver Congress™ 2022

Investegate announcements from INVENTIVA, Inventiva announces three scientific presentations at the EASL International Liver Congress™ 2022

New yorkUnited statesUnited kingdomCity ofHugo hervManalf abdelmalekMartine baudinAude lepreuxSanjaykumar patelSven francquePascaline clercMichaelp cooremanJean louis junienLucile dzenPhilippe huot marchandJean louis abitbol

INVENTIVA: Inventiva announces three scientific presentations at the EASL International Liver Congress 2022

Three poster presentations showing the beneficial effects of lanifibranor on markers of cardiometabolic health in patients with non-cirrhotic NASH fibrosis independent of weight gain observed.the reduction

New yorkUnited statesUnited kingdomCity ofHugo hervManalf abdelmalekMartine baudinAude lepreuxSanjaykumar patelSven francqueMichaelp cooremanPascaline clercLucile dzenJean louis junienPhilippe huot marchandJean louis abitbol

Zydus announces first patient randomised in EVIDENCES-X™ Phase II(b) clinical trial of Saroglitazar Mg in NASH

Zydus announces first patient randomised in EVIDENCES-X™ Phase II(b) clinical trial of Saroglitazar Mg in NASH
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesSven francqueNaga chalasaniPankajr patelArunj sanyalDivision of gastroenterologyIndiana university school of medicineVirginia commonwealth universityUs food drug administrationEuropean medicines agencyCadila healthcare ltdDepartment of medicineCadila healthcareTime zoneSaroglitazar magnesiumNon alcoholic steatohepatitis